Rare Inherited EGFR Mutation Linked to Dramatically Increased Lung Cancer Risk
The Storied Career Of Clinical Physicist Dr. Charlie Ma: From Philadelphia To Cancer Centers Worldwide
Building a System of Focused Care for Lobular Breast Cancer
Dana-Farber/Boston Children's Named the Top Pediatric Cancer Program in the Nation for 2026-2027
Dana-Farber Science Backs Development of Targeted Therapy for Rare GIST Cancer
Targeting CDK2 Could Boost Immunotherapy Response in Patients With a Wide Range of Cancers, According to Dana-Farber Science
FDA Approves Daraxonrasib for Metastatic Pancreatic Cancer Following Landmark Clinical Trial Led by Dana-Farber
Redefining Treatment Timelines for Platinum-Resistant Ovarian Cancer
FDA Approves First CELMoD Agent, with Dana-Farber Helping Advance its Development
Dana-Farber Investigators Develop Protein Degrader Discovery Platform and Find First-in-Kind Metabolically Activated Molecular Glue Degrader
Collaborative Team Doubles Number of In Vitro Patient-Derived Cancer Models Available for Research
Two New Carol and Louis Della Penna Chairs at Fox Chase
Preserving Life and Quality of Life in Muscle-Invasive Bladder Cancer
U.S. News & World Report Names Dana-Farber Brigham Cancer Center #1 Locally, #3 Nationally for 2026-2027
U.S. News & World Report Recognizes Fox Chase Cancer Center Among Nation’s Best Hospitals for Cancer Care
Showing 1 - 15 of 1086 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...73 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
